In the lung, Nrf2 overexpression or pharmacologic activation attenuates radiation-induced skin injury and alleviates pulmonary inflammation and fibrosis, whereas Nrf2 deficiency exacerbates tissue radiosensitivity. The gene discussed is NFE2L2; the disease is fibrosis.